Former Enovis CEO Matthew Trerotola Joins CD&R as Operating Advisor

In a strategic move that highlights its commitment to enhancing operational efficiency, CD&R (Clayton, Dubilier & Rice) has recently appointed Matthew Trerotola, the former Chief Executive Officer of Enovis Corporation, as an Operating Advisor. This addition is part of CD&R's effort to drive growth within its healthcare and industrial investments.

Trerotola's Journey to CD&R

Matthew Trerotola took the helm at Colfax Corporation, which later became Enovis, in 2015, when it operated primarily as a diversified industrial company. Under his leadership, the company shifted from this model and began focusing more narrowly on two growing areas: ESAB, a leader in fabrication technology, and Enovis, the medical technology business. In 2023, he was appointed Chairman of the Board.

His tenure at Enovis was marked by significant achievements; Trerotola oversaw a notable transformation where he guided the company towards becoming a global frontrunner in key orthopedic segments between 2019 and 2025. This period was characterized by vigorous growth, including 20 strategic acquisitions that expanded the company's portfolio. Trerotola's strategic vision also led to a successful rebranding and a lineup of new product launches, resulting in the business doubling in scale while achieving strong organic growth in the high single digits.

A noteworthy aspect of his approach was the introduction of the Enovis Growth Excellence framework, which served as a specialized management system designed to promote continuous improvement and spur innovation across the organization.

What This Means for CD&R

Ravi Sachdev, a Partner at CD&R, expressed confidence in Trerotola's capabilities, noting his extensive experience in refining the performance of healthcare and industrial companies. “Matt is already well known to CDR and has spent his career positioning healthcare and industrial companies to perform better,” he stated. Trerotola's proven track record of fostering strong leadership teams and cultivating a productive corporate culture aligns seamlessly with CD&R's investment strategies in these sectors.

With the addition of Trerotola, CD&R is looking to leverage his expertise in sourcing and evaluating new investment opportunities while providing support to management teams within their existing portfolio. This partnership is expected to further enhance value creation across CD&R's investments.

Trerotola himself has expressed enthusiasm about the new role, stating, “Working with CDR is an exciting opportunity to build on the Firm's track record of corporate transformation.” He expressed admiration for CD&R's disciplined investment philosophy and its focus on operational excellence and distinctive company culture.

Trerotola's Background

Before his tenure at Enovis, Trerotola held the position of Executive Vice President at DuPont, managing a significant revenue stream of $6.3 billion in high-performance and electronic materials. His career trajectory includes progressive roles at Danaher Corporation, where he was Vice President and Group Executive overseeing a life sciences platform boasting revenues of $2.5 billion.

Currently, he sits on the boards of several organizations, including AptarGroup, Inc., and Solstice Advanced Materials, alongside community service endeavors supporting the Boys and Girls Clubs of Delaware. Trerotola holds a B.S. in Chemical Engineering from the University of Virginia and an M.B.A. from Harvard Business School, underscoring his strong academic background in engineering and business management.

CD&R's Legacy

Founded in 1978, CD&R has built a reputation as a leading private investment firm that aims to generate robust investment returns through fostering more resilient and sustainable businesses. By combining adept investment strategies with deep operational insights, CD&R partners closely with management teams across diverse industries including industrials, healthcare, consumer products, technology, and financial services. With its headquarters in New York and an office in London, CD&R remains committed to a long-term perspective on value creation, positively impacting the businesses it supports.

For those who wish to learn more about CD&R and its investment activities, additional information can be found on their website at www.cdr.com or through their LinkedIn profile.

Conclusion

The appointment of Matthew Trerotola as Operating Advisor is expected to reinforce CD&R's position in the healthcare and industrial sectors, leveraging his experience in transforming businesses for sustained growth. This strategic move highlights CD&R's commitment to operational excellence and continuity in leadership, ultimately setting the stage for further innovation and value creation.